Aloracetam

Aloracetam
Clinical data
ATC code	none;
Legal status
Legal status	In general: unscheduled;
Identifiers
	IUPAC name N-[2-(3-formyl-2,5-dimethylpyrrol-1-yl)ethyl]acetamide;
CAS Number	119610-26-3 ;
PubChem CID	178134;
ChemSpider	155069 ;
UNII	U0RKZ75D0T;
ChEMBL	ChEMBL2104637;
CompTox Dashboard (EPA)	DTXSID10152524 ;
Chemical and physical data
Formula	C11H16N2O2
Molar mass	208.257 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1=CC(=C(N1CCNC(=O)C)C)C=O;
	InChI InChI=1S/C11H16N2O2/c1-8-6-11(7-14)9(2)13(8)5-4-12-10(3)15/h6-7H,4-5H2,1-3H3,(H,12,15) ; Key:ZUQSGZULKDDMEW-UHFFFAOYSA-N ;
	(verify)

Aloracetam is a nootropic drug of the racetam family, developed by Aventis for the treatment of Alzheimer's disease.^[1]

References

^ Fischer F, Matthisson M, Herrling P. List of Drugs in Development for Neurodegenerative Diseases. Neurodegenerative Diseases 2004;1:50–70.

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.